Putative salivary biomarkers useful to differentiate patients with fibromyalgia.

[en] Fibromyalgia (FM) is a chronic pain disorder characterized by widespread pain and associated with unspecific symptoms. So far, no laboratory tests have been validated. The aim of the present study was to investigate the presence in saliva of potential diagnostic and/or prognostic biomarkers which could be useful for the management of FM patients. Specifically, the salivary profile of FM patients was compared with those of healthy subjects, subjects suffering migraine (model of non-inflammatory chronic pain), and patients affected by rheumatoid arthritis (model of inflammatory chronic pain). For proteomics analysis 2-DE and SELDI-TOF-MS were applied. From 2-DE serotransferrin and alpha-enolase were found differentially expressed in FM. Hence, their expression was validated by ELISA together with phosphoglycerate-mutase-I and transaldolase, which were found in a previous work. Moreover, ROC curve was calculated by comparing FM patients versus control subjects (healthy plus migraine) to investigate the discriminative power of biomarkers. The best performance was obtained by combining alpha-enolase, phosphoglycerate-mutase-I and serotransferrin. On the other hand, none of the candidate proteins showed a statistical correlation with clinical features. Finally, preliminary SELDI analysis highlighted two peaks whose identification need to be validated. Overall, these results could be useful in supporting the clinical diagnosis of FM. SIGNIFICANCE: FM is one of the most common chronic pain condition which is associated with significant disability. The fibromyalgic pain is a peculiar characteristic of this disease and FM patients suffer from reduced quality of life, daily functioning and productivity. Considering the deep complexity of FM, the discovery of more objective markers is crucial for supporting clinical diagnosis. Therefore, the aim of the present study was the selection of biomarkers effectively associated with fibromyalgic pain which will enable clinicians to achieve an unambiguous diagnosis, and to improve approaches to patients' management. We defined a panel of 3 salivary proteins which could be one of the criteria to be taken into account. Consequently, the identification of disease salivary biomarkers could be helpful in detecting FM clusters and targeted treatment. Actually, our future perspective foresees to develop a simple, rapid and not invasive point-of-care testing which will be of use during the diagnostic process. In addition, the present results can offer a clue for shedding light upon the complex entity of such a disease like FM.

Disciplines :

Rheumatology

Author, co-author :

Ciregia, Federica ; Université de Liège - ULiège > I3-Rheumatology

Giacomelli, Camillo

Giusti, Laura

Boldrini, Claudia

Piga, Isabella

Pepe, Pasquale

Consensi, Arianna

Gori, Sara

Lucacchini, Antonio

Mazzoni, Maria R.

Bazzichi, Laura

Language :

English

Title :

Putative salivary biomarkers useful to differentiate patients with fibromyalgia.

Publication date :

2019

Journal title :

Journal of Proteomics

ISSN :

1874-3919

eISSN :

1876-7737

Publisher :

Elsevier, Netherlands

Volume :

190

Pages :

44-54

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 17 June 2021

Statistics

Number of views

54 (2 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Clauw, D.J., Fibromyalgia. A clinical review. JAMA 311 (2014), 1547–1555.
Queiroz, L.P., Worldwide epidemiology of fibromyalgia. Curr. Pain Headache Rep., 17, 2013, 356.
Skaer, T.L., Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. PharmacoEconomics 32 (2014), 457–466.
Weir, P.T., Harlan, G.A., Nkoy, F.L., Jones, S.S., Hegmann, K.T., Gren, L.H., Lyon, J.L., The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J. Clin. Rheumatol. 12 (2006), 124–128.
Wolfe, F., Smythe, H.A., Yunus, M.B., Bennett, R.M., Bombardier, C., Goldenberg, D.L., Tugwell, P., Campbell, S.M., Abeles, M., Clark, P., Fam, A.G., Farber, S.J., Fiechtner, J.J., Franklin, C.M., Gatter, R.A., Hamaty, D., Lessard, J., Lichtbroun, A.S., Masi, A.T., Mccain, G.A., Reynolds, W.J., Romano, T.J., Russell, I.J., Sheon, R.P., The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33 (1990), 160–172.
Wolfe, F., Clauw, D.J., Fitzcharles, M.A., Goldenberg, D.L., Katz, R.S., Mease, P., Russell, A.S., Russell, I.J., Winfield, J.B., Yunus, M.B., The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 62 (2010), 600–610.
Wolfe, F., Clauw, D.J., Fitzcharles, M.A., Goldenberg, D.L., Häuser, W., Katz, R.S., Mease, P., Russell, A.S., Russell, I.J., Winfield, J.B., Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 38 (2011), 1113–1122.
Wolfe, F., Fitzcharles, M.A., Goldenberg, D.L., Häuser, W., Katz, R.L., Mease, P.J., Russell, A.S., Jon Russell, I., Walitt, B., Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia. Arthritis Care Res. 68 (2016), 652–659.
Wolfe, F., Clauw, D.J., Fitzcharles, M.A., Goldenberg, D.L., Häuser, W., Katz, R.L., Mease, P.J., Russell, A.S., Russell, I.J., Walitt, B., 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 46 (2016), 319–329.
Ablin, J.N., Wolfe, F., A comparative evaluation of the 2011 and 2016 criteria for fibromyalgia. J. Rheumatol. 44 (2017), 1271–1276.
Sturgill, J., McGee, E., Menzies, V., Unique cytokine signature in the plasma of patients with fibromyalgia. J Immunol Res, 2014, 2014, 938576.
Wallace, D.J., Gavin, I.M., Karpenko, O., Barkhordar, F., Gillis, B.S., Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis. Rheumatol. Int. 35 (2015), 991–996.
Rodriguez-Pintó I., Agmon-Levin, N., Howard, A., Shoenfeld, Y., Fibromyalgia and cytokines. Immunol. Lett. 161 (2014), 200–203.
Giacomelli, C., Talarico, R., Bombardieri, S., Bazzichi, L., The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management. Expert. Rev. Clin. Immunol. 9 (2013), 1069–1076.
Behm, F.G., Gavin, I.M., Karpenko, O., Lindgren, V., Gaitonde, S., Gashkoff, P.A., Gillis, B.S., Unique immunologic patterns in fibromyalgia. BMC Clin. Pathol., 12, 2012, 25.
Suk, J.H., Lee, J.H., Kim, J.M., Association between thyroid autoimmunity and fibromyalgia. Exp. Clin. Endocrinol. Diabetes 120 (2012), 401–404.
Cerdá-Olmedo, G., Mena-Durán, A.V., Monsalve, V., Oltra, E., Identification of a MicroRNA signature for the diagnosis of fibromyalgia. PLoS One, 10, 2015, e0121903.
Masotti, A., Baldassarre, A., Guzzo, M.P., Iannuccelli, C., Barbato, C., Di Franco, M., Circulating microRNA profiles as liquid biopsies for the characterization and diagnosis of fibromyalgia syndrome. Mol. Neurobiol., 54, 2017, 7129.
Bjersing, J.L., Bokarewa, M.I., Mannerkorpi, K., Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study. Rheumatol. Int. 35 (2015), 635–642.
Bjersing, J.L., Lundborg, C., Bokarewa, M.I., Mannerkorpi K Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One, 8, 2013, e78762.
Lee, Y.H., Choi, S.J., Ji, J.D., Song, G.G., Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol. Int. 32 (2012), 417–426.
Ablin, J.N., Buskila, D., Fibromyalgia syndrome—novel therapeutic targets. Maturitas 75 (2013), 335–340.
Bazzichi, L., Da Valle, Y., Rossi, A., Giacomelli, C., Sernissi, F., Giannaccini, G., Betti, L., Ciregia, F., Giusti, L., Scarpellini, P., Dell'Osso, L., Marazziti, D., Bombardieri, S., Lucacchini, A., A multidisciplinary approach to study the effects of balneotherapy and mud-bath therapy treatments on fibromyalgia. Clin. Exp. Rheumatol. 31 (2013), S111–20.
Ciregia, F., Giusti, L., Da Valle, Y., Donadio, E., Consensi, A., Giacomelli, C., Sernissi, F., Scarpellini, P., Maggi, F., Lucacchini, A., Bazzichi, L., A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers. J. Transl. Med., 11, 2013, 243.
Baldini, C., Giusti, L., Ciregia, F., Da Valle, Y., Giacomelli, C., Donadio, E., Sernissi, F., Bazzichi, L., Giannaccini, G., Bombardieri, S., Lucacchini, A., Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res. Ther., 13, 2011, R194.
Ruggiero, V., Era, B., Cacace, E., Molin, L., Corda, M., Fais, A., Utzeri, S., A preliminary study on serum proteomics in fibromyalgia syndrome. Clin. Chem. Lab. Med. 52 (2014), e207–10.
Olausson, P., Ghafouri, B., Ghafouri, N., Gerdle, B., Specific proteins of the trapezius muscle correlate with pain intensity and sensitivity - an explorative multivariate proteomic study of the trapezius muscle in women with chronic widespread pain. J. Pain Res. 9 (2016), 345–356.
Bazzichi, L., Ciregia, F., Giusti, L., Baldini, C., Giannaccini, G., Giacomelli, C., Sernissi, F., Bombardieri, S., Lucacchini, A., Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin. Appl. 3 (2009), 1296–1304.
Ndao, M., Rainczuk, A., Rioux, M.C., Spithill, T.W., Ward, B.J., Is SELDI-TOF a valid tool for diagnostic biomarkers?. Trends Parasitol. 26 (2010), 561–567.
Al-Tarawneh, S.K., Bencharit, S., Applications of surface-enhanced laser desorption /ionization time-of-flight (SELDI-TOF) mass spectrometry in defining salivary proteomic profiles. Open Dent. J. 3 (2009), 74–79.
Giusti, L., Baldini, C., Bazzichi, L., Ciregia, F., Tonazzini, I., Mascia, G., Giannaccini, G., Bombardieri, S., Lucacchini, A., Proteome analysis of whole saliva: a new tool for rheumatic diseases–the example of Sjögren's syndrome. Proteomics 7 (2007), 1634–1643.
Ciregia, F., Giusti, L., Ronci, M., Bugliani, M., Piga, I., Pieroni, L., Rossi, C., Marchetti, P., Urbani, A., Lucacchini, A., Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: a proteomic study. Mol. BioSyst. 11 (2015), 1696–1707.
Scherl, A., Tsai, Y.S., Shaffer, S.A., Goodlett, D.R., Increasing information from shotgun proteomic data by accounting for misassigned precursor ion masses. Proteomics 8 (2008), 2791–2797.
Cristaudo, A., Bonotti, A., Simonini, S., Vivaldi, A., Guglielmi, G., Ambrosino, N., Chella, A., Lucchi, M., Mussi, A., Foddis, R., Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J. Thorac. Oncol. 6 (2011), 1587–1593.
Chen, Q., Connor, J.R., Beard, J.L., Brain iron, transferrin and ferritin concentrations are altered in developing iron-deficient rats. J. Nutr. 125 (1995), 1529–1535.
Ortancil, O., Sanli, A., Eryuksel, R., Basaran, A., Ankarali, H., Association between serum ferritin level and fibromyalgia syndrome. Eur. J. Clin. Nutr. 64 (2010), 308–312.
Mizuno, S., Mihara, T., Miyaoka, T., Inagaki, T., Horiguchi, J., CSF iron, ferritin and transferrin levels in restless legs syndrome. J. Sleep Res. 14 (2005), 43–47.
Earley, C.J., Connor, J.R., Beard, J.L., Malecki, E.A., Epstein, D.K., Allen, R.P., Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54 (2000), 1698–1700.
Mader, R., Koton, Y., Buskila, D., Herer, P., Elias, M., Serum iron and iron stores in non-anemic patients with fibromyalgia. Clin. Rheumatol. 31 (2012), 595–599.
Nashida, T., Yoshie, S., Imai, A., Shimomura, H., Transferrin secretory pathways in rat parotid acinar cells. Arch. Biochem. Biophys. 487 (2009), 131–138.
van't Hof, W., Veerman, E.C., Nieuw Amerongen, A.V., Ligtenberg, A.J., Antimicrobial defense systems in saliva. Monogr. Oral Sci. 24 (2014), 40–51.
Weinberg, E.D., Human lactoferrin: a novel therapeutic with broad spectrum potential. J. Pharm. Pharmacol., 53(10), 2001, 1303.
Principe, M., Borgoni, S., Cascione, M., Chattaragada, M.S., Ferri-Borgogno, S., Capello, M., Bulfamante, S., Chapelle, J., Di Modugno, F., Defilippi, P., Nisticò P., Cappello, P., Riganti, C., Leporatti, S., Novelli, F., Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J. Hematol. Oncol., 10(1), 2017 Jan 13, 16.
Hsiao, K.C., Shih, N.Y., Fang, H.L., Huang, T.S., Kuo, C.C., Chu, P.Y., et al. Surface alpha-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target. PLoS One, 8, 2013, e69354.
Song, Y., Luo, Q., Long, H., Hu, Z., Que, T., Zhang, X., et al. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol. Cancer, 13, 2014, 65.
Fu, Q.F., Liu, Y., Fan, Y., Hua, S.N., Qu, H.Y., Dong, S.W., et al. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. J. Hematol. Oncol., 8, 2015, 22.
Moscato, S., Pratesi, F., Sabbatini, A., Chimenti, D., Scavuzzo, M., Passatino, R., Bombardieri, S., Giallongo, A., Migliorini, P., Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur. J. Immunol. 30 (2000), 3575–3584.
Bruschi, M., Sinico, R.A., Moroni, G., Pratesi, F., Migliorini, P., Galetti, M., Murtas, C., Tincani, A., Madaio, M., Radice, A., Franceschini, F., Trezzi, B., Bianchi, L., Giallongo, A., Gatti, R., Tardanico, R., Scaloni, A., D'Ambrosio, C., Carnevali, M.L., Messa, P., Ravani, P., Barbano, G., Bianco, B., Bonanni, A., Scolari, F., Martini, A., Candiano, G., Allegri, L., Ghiggeri, G.M., Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI. J. Am. Soc. Nephrol. 25 (2014), 2483–2498.
Migliorini, P., Pratesi, F., Bongiorni, F., Moscato, S., Scavuzzo, M., Bombardieri, S., The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun. Rev. 1 (2002), 168–173.
Moodie, F.D., Leaker, B., Cambridge, G., Totty, N.F., Segal, A.W., Alphaenolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int. 43 (1993), 675–681.
Terrier, B., Degand, N., Guilpain, P., Servettaz, A., Guillevin, L., Mouthon, L., Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun. Rev. 6 (2007), 176–182.
Kimura, A., Sakurai, T., Koumura, A., Yamada, M., Hayashi, Y., Tanaka, Y., Hozumi, I., Tanaka, R., Takemura, M., Seishima, M., Inuzuka, T., High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases. J. Neuroimmunol. 219 (2010), 105–108.
Zephir, H., Almeras, L., El Behi, M., Dussart, P., de Seze, J., Steibel, J., Trifilieff, E., Dubucquoi, S., Dessaint, J.P., Vermersch, P., Prin, L., Lefranc, D., Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 179 (2006), 53–64.
Akbas, A., Inanir, A., Benli, I., Onder, Y., Aydogan, L., Evaluation of some antioxidant enzyme activities (SOD and GPX) and their polymorphisms (MnSOD2 Ala9Val, GPX1 Pro198Leu) in fibromyalgia. Eur. Rev. Med. Pharmacol. Sci. 18 (2014), 1199–1203.
Yildirim, T., Alp, R., The role of oxidative stress in the relation between fibromyalgia and obstructive sleep apnea syndrome. Eur. Rev. Med. Pharmacol. Sci. 21 (2017), 20–29.
Sánchez-Domínguez, B., Bullón, P., Román-Malo, L., Marín-Aguilar, F., Alcocer-Gómez, E., Carrión, A.M., Sánchez-Alcazar, J.A., Cordero, M.D., Oxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with fibromyalgia. Mitochondrion 21 (2015), 69–75.
Leprince, J., Bagnol, D., Bureau, R., Fukusumi, S., Granata, R., Hinuma, S., Larhammar, D., Primeaux, S., Sopkova-de Oliveiras Santos, J., Tsutsui, K., Ukena, K., Vaudry, H., The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR review 24. Br. J. Pharmacol. 174 (2017), 3573–3607.
Chartrel, N., Picot, M., El Medhi, M., Arabo, A., Berrahmoune, H., Alexandre, D., Maucotel, J., Anouar, Y., Prévost, G., The neuropeptide 26RFa (QRFP) and its role in the regulation of energy homeostasis: a mini-review. Front. Neurosci., 10, 2016, 549.